Understanding the Priority: Prevention of the Most Serious Complication
In the context of a modified radical mastectomy, the surgical procedure involves the removal of breast tissue, skin, and axillary lymph nodes. While all the listed nursing interventions are essential components of postoperative care, the question asks for the intervention that prevents the
most serious complication. In this scenario, the most serious long-term complication specifically associated with axillary lymph node dissection is
breast cancer-related lymphedema (BCRL). BCRL is a chronic, progressive condition caused by the disruption of the lymphatic system, leading to protein-rich fluid accumulation in the interstitial space of the arm. Unlike a surgical site infection or atelectasis, which can often be resolved with antibiotics or aggressive pulmonary toilet, BCRL is currently considered incurable and can result in permanent disability, recurrent infections (cellulitis), and significant psychosocial distress. Therefore, proactive education on prevention is the highest priority.
Why Arm and Shoulder Exercises are the Priority
The correct answer is demonstrating arm and shoulder exercises. The rationale is grounded in the pathophysiology of the lymphatic system and supported by high-level evidence regarding exercise-based prevention. The axillary lymph node dissection physically removes the drainage pathways for the arm. Postoperatively, the remaining lymphatic vessels must reroute fluid, a process that relies heavily on the muscle pump action of the upper extremity and external compression. Early, structured exercises facilitate this by promoting lymph drainage through the collateral lymphatic network.
Recent evidence strongly validates this proactive approach. A
1-year randomized controlled trial by Fan et al. (2026) specifically investigated the prophylactic effect of resistance training. The study found that patients who engaged in a
12-week structured exercise program post-surgery had a significantly reduced incidence of BCRL compared to the control group
[3]. This confirms that waiting until lymphedema develops is not the standard of care; rather, early mobilization under guided parameters is a critical preventive measure. The mechanism is not merely about maintaining range of motion but about actively stimulating the lymphatic system to establish new drainage paths before fluid stasis occurs.
Furthermore, the role of the rehabilitation nurse in empowering patients for self-care is crucial here. A scoping review by Rodrigues et al. (2025) mapped out the specific interventions for mastectomized women, highlighting that teaching self-management techniques, including exercise protocols, is a core function to mitigate functional decline . Even when lymphedema does occur, a network meta-analysis by Wang et al. (2025) confirms that exercise remains the mainstay of treatment, but the primary goal is always prevention . While virtual reality therapy is emerging as a novel tool for managing established lymphedema and disability, as noted in the meta-analysis by Bani Mohammad and Ahmad (2025), it is a reactive treatment, not a primary preventive strategy taught in the immediate preoperative setting .
Analysis of Other Options
Teaching deep breathing and coughing (Option 2) is critical to prevent postoperative atelectasis and pneumonia, which are serious acute complications. However, these are generally transient and reversible with standard interventions. Explaining wound care (Option 3) prevents surgical site infection, a common complication, but one that is typically manageable with antibiotics and local wound care. Discussing pain management (Option 4) is vital for comfort and facilitating mobility, but uncontrolled acute pain is not the most serious long-term complication associated with this specific surgery. The chronic, incurable nature of lymphedema elevates its prevention above these other, albeit important, concerns.
References (research sources)
- [3]
Effects of Resistance Training at Different Intensities on Preventing Breast Cancer-Related Lymphedema: A 1-Year Randomized Controlled Trial.RCT/clinical trialFan YJ, Xu HQ, Li H, Zhang ZR, Zhang SF, Du AJ, Zhou LZ, Wang Y. (2026) · DOI: 10.1016/j.clbc.2025.07.012